Printer Friendly

Growth hormone okayed.

The Food and Drug Administration last week approved the marketing of a bacterially manufactured human growth hormone. The hormone joins an insulin product as the only U.S.-approved human drugs made by recombinant DNA processes.

The approval is timely for the estimated 10,000 to 15,000 U.S. children whose pituitary glands do not produce enough of the growth-stimulating hormone. Last April the federal government halted distribution of a cadaver-derived version because three recipients had developed a rare, fatal viral disease.

A spokesperson for Genentech, Inc., in South San Francisco, makers of the newly approved version, says that for ease of marketing and to prevent medically unsubstantiated uses, such as administering the drug to children with normal pituitaries and to athletes, the company is marketing the product only through hospital pharmacies in about 150 medical centers.
COPYRIGHT 1985 Science Service, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1985, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:by Food and Drug Administration
Publication:Science News
Date:Oct 26, 1985
Previous Article:Daisy chains: cyclosporine link.
Next Article:Meteor linked to rich ores at Sudbury.

Related Articles
Short-stature treatment reevaluated.
Doin' a body good?; studies link r-BGH-produced milk and increased cancer risk.
Improvement seen in Oregon's small-business growth.
MS pills are making news.
Stem cells & MS: what the investigators see.
FDA embraces stealth tort 'reform' in proposed OTC drug rules.
Compounded drugs are dangerous concoctions, critics say.
The Whistleblower: Confessions of a Healthcare Hitman.

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters